Ads
related to: acute myeloid leukemia- Safety
Learn More About Well Characterized
Safety Profile.
- Dosing & Monitoring
Twice Daily
Oral Dosing.
- Efficacy
Durable Complete Remissions
for R/R AML Patients.
- Mechanism of Action
Inhibits Mutant IDHI and
Restores Myeloblast Differentiation
- Safety
Search results
Dallas teen who inspired hundreds to register to become blood stem cell donors dies
Fox local via AOL· 1 day agoHis story inspired more than a thousand people in North Texas to register to become blood stem cell...
Recommendations from the AML molecular MRD expert advisory board - Leukemia
Nature· 5 days agoThe standard-of-care treatment for patients with acute myeloid leukemia (AML) is being challenged by new classes of targeted therapies ...
Syrian first lady Asma Assad diagnosed with leukemia, president's office says
Associated Press via AOL· 7 days agoSyrian first lady Asma Assad has been diagnosed with leukemia, the office of President Bashar Assad...
St. Jude patient's lifesaving story: 'I was losing my ability to function at that point'
ABC 13 Lynchburg· 6 days agoDoctors diagnosed Anna with acute myeloid leukemia, an aggressive form of the disease, when she was...
7 Biotech Stocks to Put on Your Breakthrough Radar
InvestorPlace· 13 hours agoFor those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower....
Boy who died at 15 to become first millennial saint in Catholic Church: What did he do?
WJZY via Yahoo News· 4 days agoHe had also considered priesthood, his mother said, before becoming sick and dying after a battle...
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells - Leukemia
Nature· 6 days agoMyelodysplastic syndromes (MDS) are malignant bone marrow disorders characterized by ineffective hematopoiesis leading to refractory cytopenias and an increased risk of progression to
In the news | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 6 days agoAsma Assad, wife of Syrian President Bashar Assad, was diagnosed with acute myeloid leukemia -- an aggressive cancer of the bone marrow ...
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug...
CBS 47 Fresno· 4 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its ...
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
FOX21 Colorado Springs· 4 days agoOral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib) efficacy in heavily pretreated patients, including ...
Ads
related to: acute myeloid leukemia